Glivec Imatinib Mesylate
Glivec Imatinib Mesylate Tablet 100 mg (100 mg) — certified targeted therapy from Meridian Medicine Pharma. Available for bulk pharmaceutical export.
100 mg
Glivec Imatinib Mesylate 100 mg
10 Tablets per strip
Meridian Medicine Pharma
💡 Bulk pricing available — Contact us for orders of 100+ units for additional discounts. All orders include Certificate of Analysis and export documentation.
Manufactured by Meridian Medicine Pharma, Glivec Imatinib Mesylate Tablet 100 mg is a pharmaceutical-grade targeted therapy product containing Glivec Imatinib Mesylate 100 mg. The active ingredient functions as a tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity, making it effective for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This product is produced under strict GMP conditions with complete batch traceability. Export-ready with Certificate of Analysis, stability data, and documentation required for international pharmaceutical import.